Search Results

Business

Acuamark Diagnostics Welcomes Giulia Kennedy, Former Chief Scientific and Chief Medical Officer of Veracyte, to its Board of Directors

Acuamark Diagnostics has appointed Giulia Kennedy, Ph.D., formerly global chief scientific officer and chief medical officer of diagnostics company Veracyte, to its board of directors.

April 26, 2023

·

3 min read

Pharm Country

Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection

Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series A round.

July 20, 2022

·

3 min read

Business

Acuamark Diagnostics Welcomes Dr. Cedric Francois To Its Board of Directors

Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that revolutionizes the global fight against cancer with first-in-kind early-cancer detection technology, today announced that Dr. Cedric Francois has joined its Board of Directors.

June 1, 2021

·

3 min read

Policy

Radical Imaging Announces FDA Clearance for FlexView Diagnostic, its SaaS Image Viewer for Diagnostic Use.

Radical Imaging, a trailblazer in medical imaging viewer solutions, proudly announces that FlexView Diagnostic, its SaaS web DICOM viewer product, received FDA clearance for diagnostic use.

June 24, 2024

·

2 min read

Pharm Country

Quest Diagnostics Releases 2023 Corporate Responsibility Report

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

June 27, 2024

·

3 min read

Deals

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

June 11, 2024

·

3 min read

Business

Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO

Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.

June 27, 2024

·

3 min read

Business

Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin

Progentec Diagnostics, a leader in diagnostic and digital technologies for management of autoimmune diseases, announced that Bernard R. Rubin, DO, MPH, seasoned rheumatology and immunology expert, has joined Progentec’s leadership team as Chief Medical Officer.

June 17, 2024

·

2 min read

BioCapital

Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics

Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024.

June 19, 2024

·

6 min read

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.

June 18, 2024

·

1 min read